Education
About Us
Working with TipRanks
Follow Us
BiomX (PHGE)
:PHGE
PHGE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.48 - $4.99
Previous CloseN/A
Volume30.96K
Average Volume (3M)94.95K
Market Cap
$14.67M
Enterprise Value$20.43M
Total Cash (Recent Filing)$896.73K
Total Debt (Recent Filing)$500.00K
Price to Earnings (P/E)―
Beta1.74
Next Earnings
Mar 26, 2025EPS Estimate
-1.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.35
Shares Outstanding24,996,054
10 Day Avg. Volume157,170
30 Day Avg. Volume94,954
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market Cap1.39
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-16.64
Enterprise Value/Ebitda-4.60
Forecast
1Y Price Target
$2.00Price Target Upside238.98% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
BiomX News
PremiumCompany Announcements
BiomX Announces $12M Funding for BX004 Study
PremiumCompany Announcements
BiomX Inc. Reports Q3 2024 Financial Turnaround
PremiumCompany Announcements
BiomX Shares Phage Therapy Advances and Vision---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceBiomX announced 3Q24 financial results, posting EPS of $0.31 compared with an estimate of ($0.06).
Mergers And AcquisitionsThe recent merger with Adaptive Phage Therapy expanded BiomX’s pipeline with BX211, a phage-based therapy developed to treat DFO patients infected with S. aureus.
Bears Say
Operational ChallengesDue to manufacturing delays, the topline data from the BX004 study are now expected by 1H26.
---
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PHGE FAQ
What was BiomX’s price range in the past 12 months?
BiomX lowest stock price was $0.48 and its highest was $4.99 in the past 12 months.
What is BiomX’s market cap?
BiomX’s market cap is $14.67M.
When is BiomX’s upcoming earnings report date?
BiomX’s upcoming earnings report date is Mar 26, 2025 which is in 14 days.
How were BiomX’s earnings last quarter?
BiomX released its earnings results on Nov 14, 2024. The company reported -$0.31 earnings per share for the quarter, beating the consensus estimate of -$0.5 by $0.19.
Is BiomX overvalued?
According to Wall Street analysts BiomX’s price is currently Undervalued.
Does BiomX pay dividends?
BiomX does not currently pay dividends.
What is BiomX’s EPS estimate?
BiomX’s EPS estimate is -1.1.
How many shares outstanding does BiomX have?
BiomX has 24,996,054 shares outstanding.
What happened to BiomX’s price movement after its last earnings report?
BiomX reported an EPS of -$0.31 in its last earnings report, beating expectations of -$0.5. Following the earnings report the stock price went up 4.167%.
Which hedge fund is a major shareholder of BiomX?
Currently, no hedge funds are holding shares in PHGE
---
Company Description
BiomX
BiomX Ltd engages in developing bacteriophage-based therapies for the treatment and prevention of diseases stemming from dysbiosis of the microbiome. The company was founded in March 2015 and is headquartered in Ness Ziona, Israel.
---
PHGE Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a mix of positive developments and challenges. Key achievements include completing patient enrollment for a crucial trial and securing additional funding, along with a net income turnaround. However, manufacturing delays and increased expenses pose challenges. Despite these issues, the company's positive clinical results and financial runway provide a strong outlook.Read More>---
PHGE Stock 12 Month Forecast
Average Price Target
$2.00
▲(238.98% Upside)
Technical Analysis
Bluebird Bio
―
Editas Medicine
―
Intellia Therapeutics
―
Crispr Therapeutics AG
―
Foghorn Therapeutics
―
Best Analysts Covering PHGE
1 Year
1 Year Success Rate
3/20 ratings generated profit
1 Year Average Return
-53.95%
reiterated a buy rating 7 months ago
Copying Michael Higgins's trades and holding each position for 1 Year would result in 15.00% of your transactions generating a profit, with an average return of -53.95% per trade.
---